MyGevity Plus

Name: MyGevity Plus
Brand: MyGevity
SKU: MYG-PLUS
Price: 399.00 USD
Availability: InStock

Save 20% now

$399.00 $499.00 / per test

Bone health Brain Health Environmental Sensitivity Hormones Inflammation Methylation Nutrition Sleep Weight & Metabolism

Elevate Your Health with Advanced Genetic Insights

Dive deeper into your genetic blueprint with the MyGevity Plus DNA Kit, an enhanced at-home testing option that uncovers detailed, science-driven revelations about your body's unique needs—including expanded DNA methylation testing and insights into potential disease risks before they manifest, such as Alzheimer's, Dementia, inflammation, heart conditions, osteoporosis, and hormone-related issues. Processed in top-tier CLIA-certified US labs, this kit delivers a customized roadmap to vitality—empowering you to optimize methylation pathways, fine-tune hormone levels, refine dietary choices, bolster bone strength, and beyond. Secure, user-friendly, and dedicated to HIPAA privacy, it's engineered to infuse vibrancy into every stage of life.

Kit Components: Swab tool, stabilization tube, return shipping label, setup guide.

Report Access: Protected digital dashboard featuring in-depth findings, coaching sessions, and support. Standard processing: 2-3 weeks post-lab arrival.

Key Benefits:

Provides expanded DNA methylation analysis including MTHFR, MTR, MTRR, and COMT variants for detox and cellular optimization*

Pinpoints advanced risks to guide preventive measures*

Customizes eating habits for metabolic efficiency*

Boosts rest and mental sharpness through genetic clues*

Strengthens cardiovascular resilience and curbs inflammation*

Flags nutrient gaps for precise supplementation*

Balances endocrine functions for energy and mood*

Fortifies skeletal health and counters weight challenges*

Identifies disease risks early, enabling prevention for conditions like cognitive decline, cardiovascular issues, osteoporosis, methylation imbalances, and metabolic disorders*

CLIA Certified Labs

Data Never Sold

GDPR Compliant

Detailed Coverage

The Plus DNA Kit delves into 24 Reports, 70 Tests, 363 Unique SNPs via a quick cheek swab, assessing numerous genes and variants per report for a holistic, multi-gene view—surpassing single-marker tests from competitors. Our expanded DNA methylation panel goes far beyond basic MTHFR testing to evaluate MTR, MTRR, COMT, and choline pathways—providing a complete picture of your body's ability to detoxify, produce neurotransmitters, and repair DNA. Take cognitive health: Unlike basic APOE-only checks, we evaluate dozens of interconnected genes for a fuller picture of Alzheimer's and MCI risks.

In-Depth Analysis

Explores 24 Reports, 70 Tests, 363 Unique SNPs with polygenic depth

Expanded DNA Methylation Panel

Assess MTHFR, MTR, MTRR, COMT, and choline needs for complete methylation insight

Effortless Home Testing

Simple swab, no appointments needed

Tailored Strategies

Actionable plans for nutrition, hormones, methylation support, and lifestyle adjustments

Progress Monitoring

Live updates on your sample journey

Ironclad Security

Full HIPAA/GDPR adherence, encrypted data, zero sharing

Precision Labs

CLIA-certified for trustworthy outcomes

Device-Agnostic Access

View results anytime, anywhere via mobile-optimized portal

HIPAA Compliant

GDPR Compliant

At-Home Testing

Data Never Sold

CLIA Certified Labs

Real-Time Tracking

Study 1

Using Genomic Information to Guide Weight Management

Title:

NIH Working Group Report — Using Genomic Information to Guide Weight Management: From Universal to Precision Treatment

Journal:

Obesity (Silver Spring), Volume 24, Issue 1, pages 14–22, (2016)

Summary:

An official NIH trans-agency working group — drawing on researchers from Stanford, Mount Sinai, Harvard, Brown University, and the National Cancer Institute — formally established the scientific case for using genomic data to personalize weight management. The report concluded that elucidating the molecular basis of individual variability in weight change has the potential to improve treatment outcomes, and called for moving from one-size-fits-all approaches toward precision, genomics-informed interventions.

View Study

Study 2

Genetics of Human Longevity

Title:

The Contextualized Genetics of Human Longevity: JACC Focus Seminar

Journal:

Journal of the American College of Cardiology, Volume 75, Issue 21, pages 2693–2705, (2020)

Summary:

Published in the Journal of the American College of Cardiology — one of the most prestigious cardiovascular journals in medicine — this seminar from the University of Bologna uses centenarians as a scientific model to establish that longevity genes and cardiovascular disease genes are deeply interconnected, representing two sides of the same coin. The authors demonstrate that genetic risk is highly context-dependent, shifting with age, environment, and geography, and that the same allele can be protective or harmful depending on genomic context. Their central argument — that genome-environment interactions must be understood to interpret any individual's disease risk — directly supports the value of comprehensive, personalized DNA profiling.

View Study

Study 3

Genes and Athletic Performance

Title:

Genes and Athletic Performance: The 2023 Update

Journal:

Genes (Basel), Volume 14, Issue 6, page 1235, (2023)

Summary:

This comprehensive 2023 review — from researchers at the University of Stirling, Liverpool John Moores University, and Kazan State Medical University — cataloged 251 DNA polymorphisms associated with athletic performance across endurance, power, and strength categories. Of those, 128 markers were validated in two or more independent studies. The review identifies specific high-confidence genetic variants including ACTN3, PPARGC1A, AMPD1, and PPARA that reliably predict performance traits, providing a well-curated reference map for DNA-based fitness and exercise optimization.

View Study

Study 4

Genetic Testing in Dementia

Title:

Genetic Testing in Dementia — A Medical Genetics Perspective

Journal:

International Journal of Geriatric Psychiatry, Volume 36, Issue 8, pages 1158–1170, (2021)

Summary:

Researchers from the Royal Melbourne Hospital, University of Melbourne, and Monash University conducted a comprehensive review of genetic testing across the major dementia subtypes — including Alzheimer's disease, frontotemporal dementia, vascular dementia, and Parkinson's disease dementia. The review found that incorporating genetic testing into the diagnostic pathway can meaningfully reduce time to diagnosis, and that individuals with early onset (before age 65) are at increased risk of harboring identifiable genetic causes. The authors conclude that genetic testing offers significant value when integrated with appropriate clinical context and counseling.

View Study

Study 5

Cognitive Performance in the Elderly

Title:

High Homocysteine and Epistasis Between MTHFR and APOE: Association with Cognitive Performance in the Elderly

Journal:

Experimental Gerontology, Volume 76, pages 9–16, (2016)

Summary:

Scientists from the Golgi Cenci Foundation and the University of Pavia studied elderly subjects to examine how homocysteine levels and the interaction between MTHFR and APOE gene variants affect cognitive performance. The study found that individuals carrying risk variants in both MTHFR and APOE — combined with elevated homocysteine — showed significantly worse cognitive outcomes, demonstrating that the epistatic interplay between these genes compounds cognitive decline risk. The findings support genetic testing for both variants as part of a comprehensive brain health assessment.

View Study

Have a Question?
Start Here.

View more FAQ's

We believe understanding your health should feel empowering—not overwhelming. That's why we've compiled answers to the most common questions about our DNA Kits, Blood Work, Supplements, Shipping, and Data Privacy—all in one place.

This advanced kit probes deeper into your genetics across 24 reports, 70 tests and 363 Unique SNPs, from expanded DNA methylation pathways to hormone dynamics to bone integrity, offering a polygenic lens on sleep, diet, brain resilience (with APOE and beyond), and more. It equips you with a strategic plan for lifelong optimization.*

Beyond raw data, we provide transformative tools: expansive reports including comprehensive DNA methylation analysis, expert virtual consultations, and seamless ties to tailored nutrition, supplements, and daily habits—all fortified by US-based labs and unbreachable privacy.

Sign up at my.mygevityhealth.com, swab your cheek per our straightforward steps, seal and ship via prepaid mail. Expect insights in 2-3 weeks, delivered to your private online space.

Every sample runs through US CLIA labs, zeroing in on research-validated markers with multi-gene depth for nuanced, dependable intelligence.

DNA methylation is a critical biochemical process affecting detoxification, DNA repair, neurotransmitter production, and inflammation control. The Plus Kit goes beyond basic MTHFR testing to analyze MTR, MTRR, and COMT variants—giving you a complete picture of your methylation capacity. This expanded panel helps identify why you may experience fatigue, mood changes, or difficulty detoxifying, and guides targeted supplement strategies.*

Account